Classically, diabetic gastroparesis has been described as the slowing down of gastric motility in patients with diabetes, mainly associated with poorly controlled chronic hyperglycemia.20 Gastroparesis is defined as an abnormal delay in gastric emptying, in the absence of mechanical obstruction.21 Of the 30 to 50% of patients with longstanding diabetes, gastric emptying delay may or may not be associated with the gastrointestinal symptoms of nausea, vomiting, bloating, early satiety, and postprandial fullness.22,23 However, the presence of diabetic gastroparesis varies, according to the population analyzed and the diagnostic methods employed in each study.24 Acute dysglycemia Acute dysglycemia, i.e., acute episodes of either hyperglycemia or hypoglycemia, affect gastrointestinal motor function and intestinal sensitivity.25 Acute hyperglycemia has been associated with delayed gastric emptying or ileus.26 During episodes of diabetic ketoacidosis, 46% of patients present with abdominal pain, which, in large part, can be explained by gastric emptying delay and the electrolytic abnormalities the episodes tend to present with, such as hypokalemia

(2018) 12:282/full
The biochemical processes don't interfere, but the injection logistics absolutely do
We found that the ebselen could significantly promote SGN survival, decrease SGN apoptosis, and reduce intracellular ROS levels after peroxynitrite exposure in vitro , while the deficiency of GPX1 led to opposite patterns of the above effects
Buzzetti E, Pinzani M, Tsochatzis EA
10.1038/s41598-023-29117-7 65 KrishnanA.ZhangR.YaoV.TheesfeldC